![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » BMS’ Orencia Autoinjector Hits the Market
BMS’ Orencia Autoinjector Hits the Market
![](https://www.fdanews.com/ext/resources/test/Drug-Images4/Bristol_Meyers_Squibb_logo.jpg?t=1444401319&width=430)
Bristol-Myers Squibb announced Wednesday it has released its new autoinjector Orencia for adults with moderate to severe rheumatoid arthritis.
Orencia comes in three different forms: IV infusion, prefilled syringe and autoinjector.
The device is indicated for reducing the signs and symptoms of RA, deterring the advancement of structural damage due to the condition, and improving mobility. — Cynthia Jessup
Upcoming Events
-
21Oct